Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 4
2009 3
2010 5
2011 4
2012 5
2013 6
2014 1
2015 5
2016 5
2017 11
2018 4
2019 2
2020 3
2021 4
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Posch F, Silina K, Leibl S, Mündlein A, Moch H, Siebenhüner A, Samaras P, Riedl J, Stotz M, Szkandera J, Stöger H, Pichler M, Stupp R, van den Broek M, Schraml P, Gerger A, Petrausch U, Winder T. Posch F, et al. Among authors: petrausch u. Oncoimmunology. 2017 Dec 18;7(2):e1378844. doi: 10.1080/2162402X.2017.1378844. eCollection 2018. Oncoimmunology. 2017. PMID: 29416939 Free PMC article.
T Cell Engineering.
Pircher M, Schirrmann T, Petrausch U. Pircher M, et al. Among authors: petrausch u. Prog Tumor Res. 2015;42:110-35. doi: 10.1159/000437180. Epub 2015 Sep 4. Prog Tumor Res. 2015. PMID: 26383243 Review.
Searching for targets for the systemic therapy of mesothelioma.
Stahel RA, Weder W, Felley-Bosco E, Petrausch U, Curioni-Fontecedro A, Schmitt-Opitz I, Peters S. Stahel RA, et al. Among authors: petrausch u. Ann Oncol. 2015 Aug;26(8):1649-60. doi: 10.1093/annonc/mdv101. Epub 2015 Feb 26. Ann Oncol. 2015. PMID: 25722383 Free article. Review.
Novel sequential treatment strategy for patients with muscle-invasive bladder cancer (MIBC): intravesical recombinant BCG, followed by neoadjuvant chemoimmunotherapy, radical cystectomy plus pelvic lymphadenectomy and adjuvant immunotherapy - protocol of a multicentre, single arm phase 2 trial (SAKK 06/19).
Petrausch U, Spahn M, Schneider M, Hayoz S, Rentsch CA, Rothschild S, Omlin A, Cathomas R. Petrausch U, et al. BMJ Open. 2023 Jun 7;13(6):e067634. doi: 10.1136/bmjopen-2022-067634. BMJ Open. 2023. PMID: 37286312 Free PMC article.
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.
Cathomas R, Rothschild SI, Hayoz S, Bubendorf L, Özdemir BC, Kiss B, Erdmann A, Aeppli S, Mach N, Strebel RT, Hadaschik B, Berthold D, John H, Zihler D, Schmid M, Alborelli I, Schneider M, Musilova J, Spahn M, Petrausch U. Cathomas R, et al. Among authors: petrausch u. J Clin Oncol. 2023 Nov 20;41(33):5131-5139. doi: 10.1200/JCO.23.00363. Epub 2023 Aug 17. J Clin Oncol. 2023. PMID: 37590894 Clinical Trial.
[Diffuse large B-cell lymphoma].
Fuchs I, Petrausch U, Pangalu A, Schäfer N, Samaras P. Fuchs I, et al. Among authors: petrausch u. Praxis (Bern 1994). 2015 Apr 22;104(9):441-9. doi: 10.1024/1661-8157/a001998. Praxis (Bern 1994). 2015. PMID: 25900691 Review. German. No abstract available.
59 results